| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $123.1M | -54.5% |
| Cost of Revenue | $150.3M | -50.4% |
| Gross Profit | -$27.2M | +16.3% |
| R&D Expense | $9.9M | -13.8% |
| SG&A Expense | $53.7M | -29.2% |
| Operating Income | -$99.6M | +21.5% |
| Pre-tax Income | -$99.2M | +6.8% |
| Income Tax | $435K | +157.4% |
| Net Income | -$99.6M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $44.4M | -56.6% |
| Accounts Receivable | $49.1M | -54.4% |
| Inventory | $14.9M | +68.7% |
| Current Assets | $118.7M | -49.7% |
| Total Assets | $134.4M | -44.7% |
| Current Liabilities | $60.3M | -35.3% |
| Total Liabilities | $67.9M | -32.2% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$54.5M | +59.0% |
| Capital Expenditures | $985K | -3.9% |
| Investing Cash Flow | -$4.2M | -119.9% |
| Financing Cash Flow | $903K | -99.5% |
| Free Cash Flow | -$55.5M | +58.5% |
| +6.5% |
| EPS (Basic) | -$0.98 | +21.0% |
| EPS (Diluted) | -$0.98 | +21.0% |
| Stockholders' Equity |
| $66.5M |
| -53.5% |